Biomedical Engineering Reference
In-Depth Information
sulfate: implications for understanding troglitazone hepatotoxicity. Drug Metab Dispos
32: 291-294.
614. Guo GL, Choudhuri S, Klaassen CD. 2002. Induction profile of rat organic anion
transporting polypeptide 2 (oatp2) by prototypical drug-metabolizing enzyme inducers
that activate gene expression through ligand-activated transcription factor pathways.
J Pharmacol Exp Ther 300: 206-212.
615. Blaschke TF, Berk PD, Rodkey FL, Sharschmidt BF, Collison HA, Waggoner JG. 1974.
Drugs and the liver. I. Effects of glutethimide and phenobarbital on hepatic bilirubin
clearance, plasma bilirubin turn-over and carbon monoxide production in man. Biochem
Pharmacol 23: 2795-2806.
616. Whelan G, Combes B. 1975. Phenobarbital-enhanced biliary excretion of administered
unconjugated and conjugated sulfobromophthalein (BSP) in the rat. Biochem Pharmacol
24: 1283-1286.
617. Potter BJ, Ni JZ, Wolfe K, Stump D, Berk PD. 1994. Induction of a dose-related
increase in sulfobromophthalein uptake velocity in freshly isolated rat hepatocytes by
phenobarbital. Hepatology 20: 1078-1085.
618. Noe B, Hagenbuch B, Stieger B, Meier PJ. 1997. Isolation of a multispecific organic
anion and cardiac glycoside transporter from rat brain. Proc Natl Acad Sci USA94:
10346-10350.
619. Klassen CD. 1974. Effects of microsomal enzyme inducers on the biliary excretion of
cardiac glycosides. J Pharmacol Exp Ther 191: 201-211.
620. Klassen CD. 1974. Stimulation of the development of the hepatic excretory mechanism
for ouabain in newborns rats with microsomial enzyme inducers. J Pharmacol Exp Ther
191: 212-218.
621. Eaton DL, Klassen CD. 1979. Effects of microsomal enzyme inducers on carrier-mediated
transport systems in isolated rat hepatocytes. J Pharmacol Exp Ther 208: 381-385.
622. Cheng X, Maher J, Dieter MZ, Klaassen CD. 2005. Regulation of mouse organic anion-
transporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers
that activate distinct transcription factor pathways. Drug Metab Dispos 33: 1276-1282.
623. Jigorel E, Le Vee M, Boursier-Neyret C, Parmentier Y, Fardel O. 2006. Differential reg-
ulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics
activating drug-sensing receptors in primary human hepatocytes. Drug Metab Dispos
34: 1756-1763.
624. Greenberger NJ, Thomas FB. 1973. Biliary excretion of 3H-digitoxin: modification by
bile salts and phenobarbital. J Lab Clin Med 81: 241-251.
625. McClain RM, Levin AA, Posch R, Downing JC. 1989. The effect of phenobarbital on
the metabolism and excretion of thyroxine in rats. Toxicol Appl Pharmacol 99: 216-228.
626. Nevasaari K, Alakare B, Karki NT. 1976. Different effects of microsomal enzyme
inducers on the biliary excretion of digoxin. Acta Pharmacol Toxicol 39: 442-448.
627. Jung D, Hagenbuch B, Gresh L, Pontoglio M, Meier PJ, Kullak-Ublick GA. 2001.
Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-
specific OATP genes by hepatocyte nuclear factor 1 alpha. J Biol Chem 276: 37206-37214.
628. Jung D, Podvinec M, Meyer UA, Mangelsdorf DJ, Fried M, Meier PJ, Kullak-Ublick
GA. 2002. Human organic anion-transporting polypeptide OATP8 (SLC21A8) promoter
is transactivated by the farnesoid X receptor/bile acid receptor. Gastroenterology 122:
1954-1966.
Search WWH ::
Custom Search